Portfolio Lab

Guardant Health, Inc.

  • Stock
  • Ticker GH
  • ISIN US40131M1099
  • Nasdaq

Health care · Health care services · USA

$145.83 +0.16%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Guardant Health, Inc. since 10/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

GHGlobal equities (VT)

$10,000 grew to $12,487. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −91.0% in 04/2024, measured from the peak in 02/2021. It took 67 months to get back to the old peak.

1-year return
+45.4%
5-year return p.a.
+8.4%
Return p.a. since 10/2018
+20.4%
Volatility p.a.
71.4%
Largest decline
−91.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue202203232265281302335361
Gross profit124129151172182197219236
Operating income-126-111-106-99-121-121-129-133
EBITDA-116-101-97-90-111-112-120-123
Net income-111-95-100-93-128-112-120-124
Earnings per share-0.90-0.77-0.80-0.74-1.00-0.85-0.90-0.93
Balance sheet
Total assets1,4861,3441,3321,2772,0141,9151,9121,886
Liabilities1,6251,5951,6371,6312,1132,0962,1352,162
Equity-140-251-305-354-99-181-223-276
Cash5266996295803789891,0531,027
Long-term debt1,1431,1161,1161,1151,5041,5031,5031,502
Cash flow
Operating cash flow-65-63-60-35-26-66-58-24
Capital expenditure-19-4.5-5.6-10-28-5.6-12-13
Free cash flow-83-67-66-46-54-71-70-37

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +234.3%, weakest 2022 at −72.8%. 4 of 7 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026−$0.93
30 Jul 2026−$0.90
7 May 2026−$0.85
19 Feb 2026−$1.00
29 Oct 2025−$0.74
30 Jul 2025−$0.80
30 Apr 2025−$0.77
20 Feb 2025−$0.90
6 Nov 2024−$0.88
7 Aug 2024−$0.84
9 May 2024−$0.94
22 Feb 2024−$1.62

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€18bn
Market cap in trading currency
$19.7bn
Enterprise value
$20.2bn
P/E
–
P/S
15.43
P/B
–
EV/Sales
15.80
EV/EBITDA
–
Earnings yield
–
FCF yield
-1.2%

Results (last four quarters)

Revenue
$1.28bn
Gross profit
$834m
EBITDA
−$465m
Net income
−$485m
Earnings per share
−$3.68
Revenue per share
$9.45
Revenue growth
+36.1%
Earnings growth
–

Profitability

Gross margin
65.2%
Operating margin
-39.4%
Net margin
-37.9%
Return on equity
–
Return on assets
-25.7%

Balance sheet and cash flow

Cash
$1.03bn
Cash per share
$7.59
Financial debt
$1.50bn
Debt/equity %
–
Current ratio
3.60
Book value per share
−$2.04
Operating cash flow
−$173m
Free cash flow
−$232m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
135m
Volume
2.76m
Avg. volume 3 months
1.97m
Relative volume
1.4

Price and technicals

Price
$145.83
1 day
+0.2%
52-week high
$187.22
52-week low
$78.60
Distance to 52-week high
−22.1%
Distance to 52-week low
+85.5%
Distance to 50-day line
−12.7%
Distance to 200-day line
+9.1%
RSI (14)
37
Volatility 1M
55.0%

Performance

1 week
−3.9%
1 month
−10.5%
3 months
−10.6%
6 months
+22.6%
YTD
+42.8%
1 year
+46.5%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has GH performed since 10/2018?

$10,000 grew to $45,289 by 20 Nov 2026, which is +20.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is GH?

Volatility was 71.4% per year, measured on monthly returns. The largest decline from a peak was −91.0%, with the low in 04/2024.

How does GH compare with a broad equity ETF?

Over the same period Global equities (VT) returned +10.4% per year at 16.2% volatility, GH returned +20.4% at 71.4%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Guardant Health, Inc. (GH): Return and risk | Portfolio Lab